Human CD44 Antibody from EXALPHA BIOLOGICALS, INC.
Search, find, compare suppliers for anti-Human CD44 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human CD44 |
| Clone | 7F1 |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG1 |
| Format | Protein A/G purified |
| Size | 100 µg |
| Concentration | n/a |
| Applications | Flow Cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Mouse anti Human CD44 |
| Immunogen | CD44=Derived from the hybridization of mouse Sp2/0 myeloma cells with spleen cells from BALB/c mice immunized with TCR-gamma epsilon thymocytes |
| Other Names | CD44 |
| Gene, Accession # | UniProt: P16070 |
| Catalog # | 441 |
| Price | $185 |
| Order / More Info | Human CD44 Antibody from EXALPHA BIOLOGICALS, INC. |
| Product Specific References | 1. Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor ligand. Bazil V; Horejsi V J Immunol 1992 Aug 1;149(3):747-53 2. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. Lesley J; He Q; Miyake K; Hamann A; Hyman R; Kincade PW J Exp Med 1992 Jan 1;175(1):257-66 3. Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages. Camp RL; Kraus TA; Pure E Cell Biol 1991 Dec;115(5):1283-92 4. Distinct effects of two CD44 isoforms on tumor growth in vivo. Sy MS; Guo YJ; Stamenkovic I J Exp Med 1991 Oct 1;174(4):859-66 5. Participation in normal immune responses of a metastasis-inducing splice variant of CD44 [see comments] Arch R; Wirth K; Hofmann M; Ponta H; Matzku S; Herrlich P; Zoller Comment in: Science 1992 Jul 31;257(5070):614 Science 1992 Jul 31;257(5070):682-5 6. Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4. Zlotnik A; Godfrey DI; Fischer M; Suda T J Immunol 1992 Aug 15;149(4):1211-5 7. Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. Sy MS; Guo YJ; Stamenkovic I J Exp Med 1992 Aug 1;176(2):623-7 |
EXALPHA BIOLOGICALS, INC.
EXALPHA BIOLOGICALS, INC.
2 Shaker Road, Unit B101
Shirley MA 01464
P: 978-425-1370
info@exalpha.com
https://www.exalpha.com
Profile of EXALPHA BIOLOGICALS, INC.
Return to Antibodies